[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
A phase 2 trial of FES PET in Breast cancer, run by University of Utah, recorded as terminated on the registry.
Overview
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma is a phase 2 interventional study registered as NCT04252859 by University of Utah, with 44 participants recorded, started 2020-12-11 and due to reach its primary completion in 2024-12-07. Interventions recorded: [18F]Fluoroestradiol (FES) PET/CT. Conditions recorded: Invasive Lobular Breast Carcinoma.
Linked to the technology FES PET because the registry's title names it ("18f fluoroestradiol pet") and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares FES PET (oestrogen receptor imaging), Breast cancer (all types) and the tag pipeline.
- Trial18F-fluoroestradiol (FES) PET/CT for Breast Cancer
Shares FES PET (oestrogen receptor imaging), Breast cancer (all types) and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialStudy on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialIntraoperative Radiotherapy for Korean Patients With Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.